Summary
Melissa Wickremasinghe is the Trust Lead for Interstitial Lung diseases and Sarcoidosis at Imperial College Healthcare NHS trust.
Publications
Journals
Keir GJ, Maher TM, Ming D, et al., 2014, Rituximab in severe, treatment-refractory interstitial lung disease, Respirology, Vol:19, ISSN:1323-7799, Pages:353-359
Saketkoo LA, Mittoo S, Frankel S, et al., 2014, Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease–related Interstitial Lung Diseases, The Journal of Rheumatology, Vol:41, ISSN:0315-162X, Pages:792-798
Saketkoo LA, Mittoo S, Huscher D, et al., 2013, Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials, Thorax, Vol:69, ISSN:0040-6376, Pages:428-436
Singanayagam A, Manalan K, Sridhar S, et al., 2013, Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-alpha antagonist therapy, Thorax, Vol:68, ISSN:0040-6376, Pages:955-961
Thillai M, Potiphar L, Eberhardt C, et al., 2012, Obstructive lung function in sarcoidosis may be missed, especially in older white patients, European Respiratory Journal, Vol:39, ISSN:0903-1936, Pages:775-777